U.S. Markets close in 5 hrs 44 mins

GlaxoSmithKline plc (GSK.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,663.50+20.00 (+1.22%)
As of 3:01PM BST. Market open.
Interactive chart
Previous Close1,643.50
Open1,640.00
Bid1,663.50 x 175400
Ask1,664.00 x 417900
Day's Range1,630.50 - 1,665.00
52 Week Range1,363.00 - 1,745.56
Volume5,278,883
Avg. Volume8,895,582
Market Cap81.27B
Beta1.18
PE Ratio (TTM)48.78
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.01 (4.77%)
Ex-Dividend Date2017-02-23
1y Target EstN/A
  • Reuters39 minutes ago

    Gilead's HIV drug meets goal in four late-stage studies

    Gilead Sciences Inc said on Tuesday a combination of its experimental HIV drug with existing therapies met the main goal in four late-stage studies. Gilead, which already has approved treatments for HIV, is pinning its hope on the combination to better compete with Britain's GlaxoSmithKline Plc, which is working on two-drug treatment regimen for controlling the virus behind AIDS. The U.S. drugmaker evaluated the addition of its experimental drug, bictegravir, to emtricitabine/tenofovir alafenamide (FTC/TAF), which are already in use to treat HIV.

  • Zacks47 minutes ago

    The Zacks Analyst Blog Highlights: Visa, General Electric, GlaxoSmithKline, Morgan Stanley and Abbott Laboratories

    The Zacks Analyst Blog Highlights: Visa, General Electric, GlaxoSmithKline, Morgan Stanley and Abbott Laboratories

  • Reuters6 hours ago

    Novartis has assets to sell, investors wary of what it might buy

    As Novartis considers asset sales that could raise $50 billion, investors are worried any cash raised may give the Swiss drugmaker firepower for another unsuccessful megadeal. Novartis's $52 billion takeover of U.S.-based eye care giant Alcon, completed in 2011, saddled it with a business whose sales and profit have faltered two years running. Now, Chief Executive Joe Jimenez is reviewing Alcon's surgical devices and contact lens businesses, suggesting they could be valued at $25-$35 billion if he unloads them.